Intended Use

The Philips Holter Analysis System provides measurements, data, and reporting of parameters such as normal sinus rhythm, arrhythmias, QT and ST measurements, paced beats analysis and HRV, for evaluation of symptoms that may be related to rhythm disturbances of the heart in adult patients, risk assessment of arrhythmia, efficacy of antiarrhythmic therapy, pacemaker function, and symptoms related to myocardial ischemia.

Technology

A standalone software installed on general purpose PCs that analyzes ambulatory ECG recordings collected from DigiTrak XT recorders (up to 168 hours) using the Zymed Algorithm with enhancements such as improved AFIB detection using Philips ST/AR AFIB algorithm, advanced heart rate variability calculations including nonlinear HRV, and EASI derived 12-lead ECG display for visualization. It supports multiple scan and analysis modes and interoperability with clinical systems.

Performance

The system underwent rigorous non-clinical bench testing for performance and functionality including compliance with IEC 60601-2-47:2012, AAMI EC57:2012, IEC 62304, IEC 62366-1, and IEC 82304-1 standards. Human factors/usability testing and software validation were performed with all tests passed, demonstrating safety and substantial equivalence to the predicate device. No clinical trials were required.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    6/28/2024

    8 months
  • 2

    FDA Approval

    3/21/2025

Other devices from Philips Medizin Systeme Böblingen GmbH

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.